Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flonoltinib in Hydroxyurea or Interferon Resistant/Intolerant Polycythemia Vera
NCT07232290Phase 2Recruiting
- Sponsor
- Zenitar
- Start
- Sep 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flonoltinib in polycythemia vera (PV), sponsored by Zenitar. Started Sep 2025; status: recruiting.
02
Drugs
flonoltinib
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT07232290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07232290.